The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly
recognised, not only in infants, but also in older adults (aged ≥65 years). Advances in …

We retrospectively reviewed eight prospective epidemiological studies conducted between
1991 and 1995 for dual respiratory virus infection (DRVI) to determine the frequency, …

The protective effect of maternal antibody against many viral diseases has been recognized.
The use of maternal immunization has been considered as a means to augment this …

Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …

ContextWhile hospitalization rates have declined overall, hospitalizations for acute lower
respiratory tract infections have increased steadily since 1980. Development of new …

The authors conducted a 2-year, multicenter, double-blind, placebo-controlled efficacy field
trial of live, attenuated, cold-adapted, trivalent influenza vaccine administered by nasal spray …

Objective To determine whether hospital length of stay (LOS) for acute bronchiolitis is
influenced by the infecting pathogen. Design A prospective observational cohort study was …

Background This study aims to identify the causative strain of SARS-CoV-2 in a cluster of
vaccine breakthroughs. Vaccine breakthrough by a highly transmissible SARS-CoV-2 strain is …

The COVID-19 pandemic continues to spread throughout the world with an urgent need for
a safe and protective vaccine to effectuate herd protection and control the spread of SARS-…

Human respiratory syncytial virus (HRSV) is a major cause of serious lower respiratory tract
illness in infants, young children, and the elderly. To characterize the circulation patterns of …